Open access
Open access
Powered by Google Translator Translator

EBM & Clinical Trials

Science family of journals announces change to open-access policy

20 Jan, 2021 | 01:23h | UTC

Science family of journals announces change to open-access policy – Nature

See also: A new mandate highlights costs, benefits of making all scientific articles free to read – Science

Related: Open-access Science Funders Announce Price Transparency Rules for Publishers (several resources on the subject)

 


Opinion: A big science publisher is going open access. But at what cost?

19 Jan, 2021 | 01:35h | UTC

Opinion: A Big Science Publisher Is Going Open Access. But at What Cost? – Undark

Related: A new mandate highlights costs, benefits of making all scientific articles free to read – Science AND Open-access Science Funders Announce Price Transparency Rules for Publishers (several resources on the subject) AND For €9500, Nature journals will now make your paper free to read

 


Designing and undertaking randomized implementation trials: guide for researchers

19 Jan, 2021 | 01:20h | UTC

Designing and undertaking randomised implementation trials: guide for researchers – The BMJ

 

Commentary on Twitter

 


A new mandate highlights costs, benefits of making all scientific articles free to read

15 Jan, 2021 | 08:30h | UTC

A new mandate highlights costs, benefits of making all scientific articles free to read – Science

Related: Open-access Science Funders Announce Price Transparency Rules for Publishers (several resources on the subject)

 


ATS Research Statement: Informing healthcare decisions with observational research assessing causal effect

14 Jan, 2021 | 01:43h | UTC

Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement – American Journal of Respiratory and Critical Care Medicine

 


Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response

13 Jan, 2021 | 02:10h | UTC

Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response – Vaccine

 

Commentaries on Twitter

 


Blueprint for cancer research: Critical gaps and opportunities

13 Jan, 2021 | 01:36h | UTC

Blueprint for cancer research: Critical gaps and opportunities – CA: A Cancer Journal for Clinicians

Commentary: American Cancer Society Report Identifies Critical Gaps and Research Opportunities for Improved Cancer Care – The ASCO Post

 


Managing conflicts of interest in the development of health guidelines

12 Jan, 2021 | 01:41h | UTC

Managing conflicts of interest in the development of health guidelines – Canadian Medical Association Journal

Related Guidance: Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines – Annals of Internal Medicine

 


Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data

10 Jan, 2021 | 20:48h | UTC

Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data – The BMJ Opinion

 


Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action

18 Dec, 2020 | 09:52h | UTC

Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action – The Lancet Global Health

Commentaries: Pregnant women excluded from three-quarters of COVID-19 treatment trials – The Lancet AND Expert reaction to opinion piece on pregnant women and COVID-19 treatment trials – Science Media Centre

 

Commentary on Twitter (thread – click for more)

 


Publication bias: a problem that leaves us without the full picture on the benefits and harms of treatments

18 Dec, 2020 | 09:37h | UTC

Publication bias: a problem that leaves us without the full picture on the benefits and harms of treatments – Evidently Cochrane

 

Commentary on Twitter

 


Scientists fear that ‘covidization’ is distorting research: Some researchers worry that shifting priorities towards pandemic-focused science comes at the expense of other disciplines.

17 Dec, 2020 | 08:47h | UTC

Scientists fear that ‘covidization’ is distorting research – Nature

 


How a torrent of COVID science changed research publishing — in seven charts

17 Dec, 2020 | 08:48h | UTC

How a torrent of COVID science changed research publishing — in seven charts – Nature

 


2021: research and medical trends in a post-pandemic world

17 Dec, 2020 | 08:46h | UTC

2021: research and medical trends in a post-pandemic world – Nature

 


Open-access journal eLife announces ‘preprint first’ publishing model

16 Dec, 2020 | 09:53h | UTC

Open-access journal eLife announces ‘preprint first’ publishing model – Nature

 


Nature’s 10: ten people who helped shape science in 2020

16 Dec, 2020 | 09:52h | UTC

Nature’s 10: ten people who helped shape science in 2020 – Nature

 


Perspective: How Science Beat the Virus – And what it lost in the process

15 Dec, 2020 | 01:40h | UTC

How Science Beat the Virus – The Atlantic

 

Commentary from the author on Twitter (thread – click for more)

 


Systematic Review: Financial conflicts of interest are associated with favorable recommendations of drugs and devices in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews

11 Dec, 2020 | 09:18h | UTC

Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations – Cochrane Library

Summary: Conflicts of interest and recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews – Cochrane Library

 


Just published: AstraZeneca-Oxford Covid-19 vaccine shows moderate efficacy, but questions remain about the most effective dosing regimen

9 Dec, 2020 | 08:25h | UTC

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK – The Lancet

Commentaries: Oxford COVID vaccine paper highlights lingering unknowns about results – Nature AND Detailed data on AstraZeneca-Oxford Covid-19 vaccine show it has moderate efficacy – STAT AND Oxford–AstraZeneca COVID-19 vaccine efficacy – The Lancet AND Oxford COVID-19 vaccine is safe and protects against disease, first published results from phase 3 trials – The Lancet AND Expert reaction to a study on the results of phase 3 human trials of the Oxford/AZ COVID-19 vaccine – Science Media Centre

 


New vaccine data is coming: Watch out for these 3 claims

9 Dec, 2020 | 08:17h | UTC

New Vaccine Data Is Coming: Watch Out for These 3 Claims – Wired

 


Opinion: “Get ready for vaccine false side effects”. When millions of people are vaccinated, naturally occurring health problems could be wrongly attributed to vaccines

8 Dec, 2020 | 07:55h | UTC

Get Ready for False Side Effects – Science Translational Medicine

 


First-of-its-kind African trial tests common drugs to prevent severe COVID-19. “Could cheap, widely available drugs prevent patients with mild illness from becoming severely sick?”

8 Dec, 2020 | 07:46h | UTC

First-of-its-kind African trial tests common drugs to prevent severe COVID-19 – Science

 


How to write a superb literature review

8 Dec, 2020 | 07:32h | UTC

How to write a superb literature review – Nature

 


Opinion: “Put an end to publication by proclamation for Covid vaccines”

2 Dec, 2020 | 07:27h | UTC

Put An End To Publication By Proclamation For Covid Vaccines – Forbes

 


Opinion: How Prestige Journals Remain Elite, Exclusive and Exclusionary. “by announcing a €9,500 price tag, Nature has failed to enact their own diversity and inclusion pledge”

1 Dec, 2020 | 08:22h | UTC

How Prestige Journals Remain Elite, Exclusive And Exclusionary – Forbes

See also: For €9500, Nature journals will now make your paper free to read

 


Stay Updated in Your Specialty

No spam, just news.